Ambrose Kristen sold VRTX
April 2, 2024 · Form 4 insider transaction
Ambrose Kristen sold 240 shares of Vertex Pharmaceuticals Incorporated at $419.00 per share, a transaction worth $100.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
240
Price
$419.00
Total value
$100.6K
InsiderAmbrose Kristen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 2, 2024
Filing dateApril 3, 2024
Shares owned after7,500
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.